QUINSAIR

This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom

Active ingredients

The drug QUINSAIR contains one active pharmaceutical ingredient (API):

1 Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN

Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. Read about Levofloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
QUINSAIR Nebuliser solution	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02442302
Country: EE	Ravimiamet	Identifier(s): 1683121, 1849259
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114973001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 427887
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 325074
Country: IE	Health Products Regulatory Authority	Identifier(s): 88576
Country: IT	Agenzia del Farmaco	Identifier(s): 044034015, 044034027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1076058, 1090526
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132586
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100342329